BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11318958)

  • 1. Salt sensitivity in genetically hypertensive rats of the Lyon strain.
    Florin M; Lo M; Liu KL; Sassard J
    Kidney Int; 2001 May; 59(5):1865-72. PubMed ID: 11318958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect and mechanism of felodipine and valsartan on a novel salt-sensitive hypertensive rat induced by sensory denervation].
    Han YF; Su CJ; Ou BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Mar; 33(3):255-9. PubMed ID: 15929825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
    de Gasparo M; Hess P; Nuesslein-Hildesheim B; Bruneval P; Clozel JP
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats.
    Aguilar F; Lo M; Claustrat B; Saez JM; Sassard J; Li JY
    Hypertension; 2004 Jan; 43(1):87-93. PubMed ID: 14656956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable improvement of renal function after perindopril withdrawal in Lyon hypertensive rats.
    Naelten G; Liu KL; Lo M
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):240-5. PubMed ID: 21107278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of perindopril on renal medullary hemodynamics in genetically hypertensive rats.
    Liu KL; Lo M; Benzoni D
    Am J Hypertens; 2006 Jun; 19(6):617-22. PubMed ID: 16733235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
    Lantelme P; Lo M; Luttenauer L; Sassard J
    Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population.
    Bavanandan S; Morad Z; Ismail O; Chandran A; Thayaparan T; Singaraveloo M
    Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent.
    Liu KL; Sassard J; Benzoni D
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R346-51. PubMed ID: 8770133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats.
    Naelten G; Trigo LF; Lo M
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):740-5. PubMed ID: 16306796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonist.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):576-8. PubMed ID: 8800589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
    Wilkinson-Berka JL; Gibbs NJ; Cooper ME; Skinner SL; Kelly DJ
    Nephrol Dial Transplant; 2001 Jul; 16(7):1343-9. PubMed ID: 11427623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats.
    Egan EJ; Dijoud F; Gilibert S; Sassard J
    Acta Pharmacol Sin; 2008 Nov; 29(11):1296-300. PubMed ID: 18954523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of valsartan and benazeprilat in salt-loaded stroke-prone spontaneously hypertensive rats.
    Webb RL; Barclay BW; Navarrete AE; Wosu NJ; Sahota P
    Clin Exp Hypertens; 1998 Oct; 20(7):775-93. PubMed ID: 9764721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of spontaneous baroreflex impairment in lyon hypertensive rats.
    Lantelme P; Cerutti C; Lo M; Paultre CZ; Ducher M
    Am J Physiol; 1998 Sep; 275(3):R920-5. PubMed ID: 9728092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.